Searchable abstracts of presentations at key conferences in endocrinology

ea0007p202 | Steroids | BES2004

Sweat patch cortisol - a new screen for Cushing's syndrome

Prunty H , Andrews K , Reddy-Kolanu G , Quinlan P , Wood P

Analysis of sweat is well-established for the diagnosis of cystic fibrosis and for testing for drug abuse. Cortisol, cortisone and aldosterone were identified in sweat in 1948, and the presence of 11 beta hydoxysteroid dehydrogenase type 2 in the epidermis was reported in 1990. At present there are no studies of the diagnostic value of sweat cortisol measurement. We have evaluated the use of a sweat patch comprising a small 47 by 32 mm rectangle of filter paper secured by a wa...

ea0005p230 | Steroids | BES2003

Beneficial affects of regular exercise: Is it all in the hormones?

Andrews R , Wood P

Background: Diabetes increases the risk of developing coronary heart disease irrespective of glycaemic control. Cortisol and growth hormone (GH) abnormalities have been found in these patients and have been proposed as possible mechanisms for this increased risk.Regular exercise, through an unknown mechanism, can modify cardiovascular risk and so prevent or delay the progression of coronary heart disease. In this study we assessed whether an exercise program would a...

ea0005p248 | Steroids | BES2003

A non-invasive test of mild glucocorticoid resistance

Jerjes W , Wood P , Taylor N

For investigation of mild glucocorticoid resistance, dexamethasone may be inappropriate because, unlike cortisol, it crosses the blood-brain barrier and suitably low doses are difficult to titrate. Prednisolone has been proposed as an alternative but assay of cortisol as an endpoint is subject to cross-reaction with prednisolone in most ligand assays. Using capillary gas chromatography, we can distinguish urinary cortisol and prednisolone metabolites. We have compared this app...

ea0002p97 | Steroids | SFE2001

HUMAN URINARY CORTISOL METABOLITES, SALIVARY AND URINARY FREE CORTISOL AND CORTISONE: CIRCADIAN CHANGES AND EFFECT OF HYDROCORTISONE DOSING

Jerjes W , Wood P , Taylor N

Acute cortisol increase in man, whether from endogenous or exogenous sources, is associated with changes in cortisol:cortisone equilibrium. We have examined these during normal daily circadian rhythms and following treatment with hydrocortisone. Following local ethical committee approval, four adult volunteers (2 male) collected urine samples over 3 hour periods starting from midnight and over hourly periods between 0600 & 0900 to define the morning cortisol peak. They pro...

ea0008p84 | Steroids | SFE2004

Patient self-monitoring of hydrocortisone replacement

Gardner SG , Wood P , Turner HE , Shine B , Wass JAH

Background: A hydrocortisone day curve can be used to assess a patient's steroid replacement. However the need for venous samples requires patients to be admitted to hospital either over-night or as a day case and tablet times may vary compared to the patients' usual practice.Objective: The aim of this study was to determine whether patients could collect capillary or salivary cortisol at home and whether these collections were reproducible.<p class=...

ea0003p264 | Steroids | BES2002

Cortisone reductase (11 beta-hydroxysteroid dehydrogenase type 1) deficiency presenting with features of late onset congenital adrenal hyperplasia

Laing I , Adams J , Wood P , Taylor N , Ray D

A South Asian woman aged 44 years presented with longstanding hirsutism. Her periods had always been regular and she had two children. She had been treated with spironolactone and Dianette without clinical benefit and the hirsutism was managed cosmetically. Investigations showed a high serum testosterone of 6.1 nmol/l ( 1-3nmol/l) and androstenedione 25nmol/l (2-10nmol/l). Serum sex hormone binding globulin was elevated at 96 nmol/l (23-85nmol/l), with normal DHEA sulphate, 4....

ea0002p93 | Steroids | SFE2001

AMBULANT ALDOSTERONE/ ACTIVE RENIN RATIOS AS A SCREEN FOR CONN'S SYNDROME; INFLUENCE OF DRUG THERAPY

Armston A , Waller D , Krentz A , Sandeman D , Leatherdale B , Wood P

Primary hyperaldosteronism ('Conn's syndrome') may have a prevalence as high as 10% in hypertensive patients, and in some cases there may not be obvious hypokalaemia. Recently the use of a single aldosterone/ renin ('A/R') ratio has been advocated as a screening test for Conn's, and less influence by anti-hypertensive drug therapy has been claimed.We have established a cut-off for ambulant A/R ratios of 25 ng/mU using the DPC'Coat-a-Count' aldosterone method and the Nichols 'A...

ea0010p68 | Reproduction | SFE2005

Intra-follicular cortisol:cortisone (f:e) ratios in porcine antral follicles and ovarian cysts; relationship to ovarian modulators of type 1 11β-hydroxysteroid dehydrogenase (11βHSD1) activity

Sunak N , Sharp V , Wood P , Abeydeera L , Thurston L , Michael A

In the ovary, 11βHSD enzymes inter-convert cortisol (F) with its inert metabolite, cortisone (E). Porcine follicular fluid from antral follicles and spontaneous ovarian cysts contains hydrophobic compounds that inhibit NADP(H)-dependent cortisol metabolism by 11βHSD1. The aim of this study was to measure intra-follicular F:E ratios in porcine antral follicles and ovarian cysts, and determine whether F:E ratios correlate with the inhibition of 11βHSD1 by porcine ...

ea0007p218 | Steroids | BES2004

The impact of endogenous cortisone on bone and fat: demonstration of in vivo 11beta-hydroxysteroid dehydrogenase type 1 activity

Cooper M , Syddall H , Tomlinson J , Eastell R , Wood P , Stewart P , Cooper C , Dennison E

A role for local corticosteroid metabolism by 11beta-hydroxysteroid dehydrogenase type 1 (11b-HSD1) has been proposed in bone and adipose tissue physiology. In vivo, 11b-HSD1 predominantly converts inactive cortisone to active cortisol and enzyme activity is critically dependent on substrate concentration. To examine 11b-HSD1 activity in vivo we have analysed the relationship between serum cortisone and markers of bone turnover, BMD and adipose tissue mass in a c...